Posts Tagged ‘Canadian drug importation’
Trump Administration Defies 20 Years of FDA Expertise and Guidance in Finalizing Politically Motivated Drug Importation Rule
Trump Administration Defies 20 Years of FDA Expertise and Guidance in Finalizing Politically Motivated Drug Importation Rule Washington, D.C. (September 24, 2020) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Trump Administration’s Final Rule issued today on the importation of prescription drugs: “With 40…
[...]Final regulations released governing Canadian drug importation
On September 24th, 2020 the U.S. Department of Health and Human Services released a draft of finalized rulemaking for Importation of Prescription Drugs. Watch this space for the most up-to-date news.
[...]“These drugs would go through additional shipping, inspection and repackaging. Why would they be cheaper?”
In this editorial, which was published in WBUR’s Cognoscenti on September 2, 2020, writer Sarah Ruth Bates explains why Canadian drug importation is too expensive and elaborate a solution to be effective.
[...]Citizens Against Government Waste Warns Drug Importation Executive Orders Will Cost Patients in More Ways Than One
In this July 28, 2020 editorial published in the WasteWatcher blog, Elizabeth Wright argues that the administration’s Executive Order will “encourage more illegal behavior and a greater production of counterfeit drugs from countries like China, Mexico, and India.” Wright is the Director of Health and Public Policy for Citizens Against Government Waste
[...]May 20, 2020 video: Maine Importation Update
Maine submitted a state importation plan to the U.S. Department of Health and Human Services (HHS) recently to meet its own May 1, 2020 deadline. Given the deep structural flaws in both the idea of importing medicine from Canada and in Maine’s application to do so, PSM wonders if there is a better use of Maine taxpayer dollars than to continue to pursue this idea.
[...]Delaware Legislative Group Says Importation only “seems good until one understands the details.”
In January, the Delaware’s Interagency Pharmaceuticals Purchasing Study Group opined that that importation was not a viable strategy to lower prescription drug prices.
[...]Canadian drug importation is “an economic fantasy,” former Canadian health minister says.
In this editorial in The Globe and Mail, Ujjal Dosanjh, formerly a federal minister of health and a premier of British Columbia, explains that drug manufacturers have no incentive to sell Canadian provinces more medicine to fill the needs of U.S. residents. Importation will lead to drug shortages in Canada and counterfeit drug trafficking to the U.S.
[...]What Canadians Are Saying About Drug Importation, January – December 2019
What Canadians Are Saying About Drug Importation January 2019 – December 2019 Download a copy of this page. Canadians worried by plan to let Americans import drugs (8/1/2019) “It’s clear to us that whatever measures need to be put in place to prevent, for example, large-scale importation by online pharmacies or large-scale importation by large…
[...]“Importation isn’t merely impractical — it is potentially dangerous.” – Sally Pipes
This editorial by Sally Pipes was published in The Sun Journal on December 16, 2019. Pipes is president, CEO and Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute.
[...]PSM’s Executive Director Speaks on Morning Wakeup with Dave Akerly to Warn Michigan Residents about the Dangers of Drug Importation
PSM’s Executive Director Shabbir Safdar spoke with Dave Akerly on WILS in Lansing, Michigan about the importation proposal currently being debated in the Michigan House of Representatives. Safdar was enroute to the Michigan State House to participate in hearings on drug importation being held there. Here why our Executive Director has travelled to Michigan to testify at their drug importation hearing.
[...]